Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
ICICI Pru Nifty Healthcare ETF
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.19.220913587124.8861
Domestic EquitiesMAX Healthcare Institute Ltd8.60719583711.1439
Domestic EquitiesCipla Ltd.8.57667251711.1045
Domestic EquitiesDivi's Laboratories Ltd.8.19211637610.6067
Domestic EquitiesDr. Reddy's Laboratories Ltd.7.6367785479.8875
Domestic EquitiesApollo Hospitals Enterprise Ltd.7.3800130269.5552
Domestic EquitiesLupin Ltd.5.0161311916.4946
Domestic EquitiesFortis Healthcare Ltd.4.7694671876.1752
Domestic EquitiesLaurus Labs Ltd.3.9900500905.1660
Domestic EquitiesTorrent Pharmaceuticals Ltd.3.8748134845.0169
Domestic EquitiesAurobindo Pharma Ltd.3.4162360574.4231
Domestic EquitiesAlkem Laboratories Ltd.3.187372594.1267
Domestic EquitiesGlenmark Pharmaceuticals Ltd.2.9183194153.7785
Domestic EquitiesMankind Pharma Ltd.2.5343145773.2813
Domestic EquitiesBiocon Ltd.2.3826774403.0848
Domestic EquitiesZydus Lifesciences Ltd.2.3443322043.0352
Domestic EquitiesIPCA Laboratories Ltd.2.0111179192.6038
Domestic EquitiesAbbott India Ltd.1.56096722.0210
Domestic EquitiesSyngene International Ltd.1.2245244541.5854
Domestic EquitiesPiramal Pharma Ltd.1.1520796751.4916
Total 99.9953 129.4680
Cash & Cash Equivalents and Net AssetsNet Current Assets0.0037 0.0048
Cash & Cash Equivalents and Net AssetsTREPS0.0010 0.0013
Total 0.0047 0.0061
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.